May 25, 2010 – A self-expanding, drug-eluting stent (DES) that just gained CE mark clearance in Europe is designed to ensure optimal apposition in the initial hours and days after an acute myocardial infarction (AMI) procedure.
The Stentys DES continuously applies pressure to the vessel wall, even during thrombus resolution and vessel spasm, which helps avoid malapposition, a major cause of stent thrombosis.
For more information: www.stentys.com
Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial ...
October 16, 2024 
June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...
June 12, 2024 
June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...
June 04, 2024 
April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...
April 17, 2024 
March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact ...
March 08, 2024 
January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...
January 19, 2024 
November 29, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...
November 29, 2023 
July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...
July 27, 2023 
June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study ...
June 13, 2023 
March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...
March 05, 2023